FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1875333561> ?p ?o ?g. }

• W1875333561 endingPage "6350" @default.
• W1875333561 startingPage "6340" @default.
• W1875333561 abstract "Recent clinical evidence indicates that an intradermal (ID) delivery of vaccines confers superior immunogenicity as compared to a standard intramusclular or subcutaneous (SC) delivery. In this exploratory study, 600 healthy adults were randomized to 6 study groups with subgroups of young adults (20–64 years old) and older adults (65 years and older). The subjects were either injected by a novel ID injection system with a single dose of 6, 9, or 15 μg HA or two doses (21 days apart) of 15 μg HA per strain or injected by an SC injection method with a single or two doses (21 days apart) of 15 μg HA per strain. Immunogenicity was assessed using hemagglutination inhibition (HAI) titer and microneutralization titer on Days 0, 10, 21, and 42. Solicited and unsolicited adverse events were recorded for 7 and 21 days post-vaccination, respectively. In both young adults and older adults groups, the geometric titer (GMT) ratios of HAI in the ID 15 μg HA group were higher than those in the SC 15 μg HA group on both Day 10 and Day 21, while those in the ID 6 and ID 9 μg HA groups were comparable with those in the SC 15 μg HA group. The kinetics of GMTs of HAI suggested that the ID vaccine has the potential to induce the prompt immune response, which is rather hampered in older adults as seen in the SC vaccine groups. The injection-site AEs were generally mild and transient, and did not occur in a dose or dosage-dependent manner. The results of this study clearly suggest that the immunologic profile of the ID vaccine is better than that of the SC vaccine, while the safety profile of the ID vaccine is similar to that of the SC vaccine. In this exploratory study with almost 100 subjects per each group, single or two-dose administration of the ID vaccine containing 15 μg HA was suggested to be an appropriate regimen in order to prevent influenza and to reduce the associated disease burden. JAPIC Clinical Trials Information (JapicCTI-132096)." @default.
• W1875333561 created "2016-06-24" @default.
• W1875333561 creator A5008624032 @default.
• W1875333561 creator A5019445518 @default.
• W1875333561 creator A5028427123 @default.
• W1875333561 creator A5032872134 @default.
• W1875333561 creator A5059704702 @default.
• W1875333561 creator A5069661962 @default.
• W1875333561 creator A5070493761 @default.
• W1875333561 creator A5078928215 @default.
• W1875333561 date "2015-11-01" @default.
• W1875333561 modified "2023-10-13" @default.
• W1875333561 title "Immunogenicity and safety of the new intradermal influenza vaccine in adults and elderly: A randomized phase 1/2 clinical trial" @default.
• W1875333561 cites W1795752213 @default.
• W1875333561 cites W1964841465 @default.
• W1875333561 cites W1966882334 @default.
• W1875333561 cites W1976088534 @default.
• W1875333561 cites W1977526385 @default.
• W1875333561 cites W1990289558 @default.
• W1875333561 cites W1992894246 @default.
• W1875333561 cites W1993251220 @default.
• W1875333561 cites W2000620937 @default.
• W1875333561 cites W2034322687 @default.
• W1875333561 cites W2037628161 @default.
• W1875333561 cites W2045342861 @default.
• W1875333561 cites W2053809858 @default.
• W1875333561 cites W2081182462 @default.
• W1875333561 cites W2093235767 @default.
• W1875333561 cites W2095069717 @default.
• W1875333561 cites W2102847125 @default.
• W1875333561 cites W2119688614 @default.
• W1875333561 cites W2171733057 @default.
• W1875333561 cites W4240658051 @default.
• W1875333561 cites W613652217 @default.
• W1875333561 doi "https://doi.org/10.1016/j.vaccine.2015.09.010" @default.
• W1875333561 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26431983" @default.
• W1875333561 hasPublicationYear "2015" @default.
• W1875333561 type Work @default.
• W1875333561 sameAs 1875333561 @default.
• W1875333561 citedByCount "15" @default.
• W1875333561 countsByYear W18753335612016 @default.
• W1875333561 countsByYear W18753335612018 @default.
• W1875333561 countsByYear W18753335612019 @default.
• W1875333561 countsByYear W18753335612020 @default.
• W1875333561 countsByYear W18753335612021 @default.
• W1875333561 countsByYear W18753335612022 @default.
• W1875333561 countsByYear W18753335612023 @default.
• W1875333561 crossrefType "journal-article" @default.
• W1875333561 hasAuthorship W1875333561A5008624032 @default.
• W1875333561 hasAuthorship W1875333561A5019445518 @default.
• W1875333561 hasAuthorship W1875333561A5028427123 @default.
• W1875333561 hasAuthorship W1875333561A5032872134 @default.
• W1875333561 hasAuthorship W1875333561A5059704702 @default.
• W1875333561 hasAuthorship W1875333561A5069661962 @default.
• W1875333561 hasAuthorship W1875333561A5070493761 @default.
• W1875333561 hasAuthorship W1875333561A5078928215 @default.
• W1875333561 hasBestOaLocation W18753335611 @default.
• W1875333561 hasConcept C126322002 @default.
• W1875333561 hasConcept C159654299 @default.
• W1875333561 hasConcept C168563851 @default.
• W1875333561 hasConcept C182072434 @default.
• W1875333561 hasConcept C197934379 @default.
• W1875333561 hasConcept C203014093 @default.
• W1875333561 hasConcept C205545832 @default.
• W1875333561 hasConcept C22070199 @default.
• W1875333561 hasConcept C22889606 @default.
• W1875333561 hasConcept C2780689484 @default.
• W1875333561 hasConcept C2780868878 @default.
• W1875333561 hasConcept C32611913 @default.
• W1875333561 hasConcept C71924100 @default.
• W1875333561 hasConcept C8891405 @default.
• W1875333561 hasConceptScore W1875333561C126322002 @default.
• W1875333561 hasConceptScore W1875333561C159654299 @default.
• W1875333561 hasConceptScore W1875333561C168563851 @default.
• W1875333561 hasConceptScore W1875333561C182072434 @default.
• W1875333561 hasConceptScore W1875333561C197934379 @default.
• W1875333561 hasConceptScore W1875333561C203014093 @default.
• W1875333561 hasConceptScore W1875333561C205545832 @default.
• W1875333561 hasConceptScore W1875333561C22070199 @default.
• W1875333561 hasConceptScore W1875333561C22889606 @default.
• W1875333561 hasConceptScore W1875333561C2780689484 @default.
• W1875333561 hasConceptScore W1875333561C2780868878 @default.
• W1875333561 hasConceptScore W1875333561C32611913 @default.
• W1875333561 hasConceptScore W1875333561C71924100 @default.
• W1875333561 hasConceptScore W1875333561C8891405 @default.
• W1875333561 hasIssue "46" @default.
• W1875333561 hasLocation W18753335611 @default.
• W1875333561 hasLocation W18753335612 @default.
• W1875333561 hasOpenAccess W1875333561 @default.
• W1875333561 hasPrimaryLocation W18753335611 @default.
• W1875333561 hasRelatedWork W1908731892 @default.
• W1875333561 hasRelatedWork W1963590894 @default.
• W1875333561 hasRelatedWork W2032800667 @default.
• W1875333561 hasRelatedWork W2038899530 @default.
• W1875333561 hasRelatedWork W2132204826 @default.
• W1875333561 hasRelatedWork W2375902157 @default.
• W1875333561 hasRelatedWork W2394473907 @default.
• W1875333561 hasRelatedWork W2423096141 @default.

• next